Amal M. Johnson - 08 Nov 2022 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role: Director
Signature: By: Donna Spinola For: Johnson, Amal M.
Issuer symbol: ISRG
Transactions as of: 08 Nov 2022
Net transactions value: -$1,183,212
Form type: 4
Filing time: 09 Nov 2022, 16:17:44 UTC
Previous filing: 09 Sep 2022
Next filing: 05 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISRG	Common Stock	Options Exercise	$342,692	+6,375	+57%	$53.76^*	17,599	08 Nov 2022	Direct	F1
transaction	ISRG	Common Stock	Sale	$1,525,904	-6,375	-36%	$239.36	11,224	08 Nov 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISRG	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-6,375	-100%	$0.000000^*	0	08 Nov 2022	Common Stock	6,375	$53.76	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 26, 2023.
F2	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $237.71 to $242.18 as follows: 3,103 shares sold at $237.71 - $238.69; 1,704 shares sold at $238.77 - $239.64; 390 shares sold at $239.85 - $240.79; and 1,178 shares sold at $241.46 - $242.18. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3	Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.